Newest
-
2025 Friendly Shandong New Year Gala·Dongying Cultural and Tourism Carnival Opened in Dongying
-
Kantar Group announces the proposed sale of Kantar Media
-
Positive phone call offers hope of new beginning for ties that will bear fruit: China Daily editorial
-
Hong Kong Airlines Takes Off to Australia's Gold Coast Bringing Popular Travel Option for the Chinese New Year
Food
-
Soul App and Fudan University's Center for Communication and State Governance Research Unveil 2025 Social Trend Keywords: Embracing the Era of Self-Pleasure and Enchanting the World
SHANGHAI,Jan. 7,2025--Chinese Gen Z is embarking on an unparalleled quest for self-exploration. In a world that is growing ever more dynamic,this generation is seeking stability in their social engage
01-08
Details -
Avenzo Therapeutics and DualityBio Announce Exclusive Global License for Potential Best-In-Class EGFR/HER3 Antibody-Drug Conjugate
Avenzo to receive exclusive global license (excluding Greater China) for development,manufacturing and commercialization of potential best-in-class EGFR/HER3 antibody-drug conjugate
01-08
Details -
GIGABYTE Unveils a diverse lineup of AI PCs with Groundbreaking GiMATE AI Agent at CES 2025
TAIPEI,Jan. 8,2025-- GIGABYTE,the world\'s leading computer brand,unveiled its next-gen AI PCs at CES 2025. GiMATE,a groundbreaking AI agent for seamless hardware and software control,takes center sta
01-08
Details -
ZWO Unveils Seestar S30: The Next Frontier in Accessible Astrophotography at CES 2025
SUZHOU,China,Jan. 3,2025-- ZWO,a leader in astrophotography and imaging solutions,is redefining the stargazing experience with the launch of the Seestar S30 at CES 2025. Compact,portable,and packed wi
01-06
Details -
Innovent Announces Second New Drug Application of DOVBLERON ® (Taletrectinib Adipate Capsule, ROS1 Inhibitor) was Approved by China's National Medical Products Administration
SAN FRANCISCO and SUZHOU,China,Jan. 3,2025-- Innovent Biologics,Inc. ("Innovent") (HKEX: 01801),a world-class biopharmaceutical company that develops,manufactures and commercializes high qua
01-06
Details -
YARBO TO SHOWCASE UPGRADES TO ITS INNOVATIVE MODULAR YARD CARE ROBOT AT CES 2025 IN LAS VEGAS
LAS VEGAS,Jan. 3,2025--Yarbo,the innovative company redefining outdoor automation,is excited to announce its participation atCES2025.Yarbo will be showcasing its cutting-edge lineup of outdoor robotic
01-06
Details -
Deng Guoxue, the bright messenger of the "Belt and Road": light up international projects with the light of technology
SHIZUISHAN,China,Jan. 3,2025-- In the grand blueprint of the "Belt and Road",many outstanding contributors have emerged,andDeng Guoxue of the Metrology Institute of State Grid Shizuishan Pow
01-06
Details -
Nona Biosciences Announces Update on Its Collaborator DualityBio's Antibody-Drug Conjugate (ADC) Collaboration with BeiGene
CAMBRIDGE,Mass.,Jan. 3,2025-- Nona Biosciences,a global biotechnology company providing a total solution from "Idea to IND" (I to ITM),today announcedthat BeiGene. Ltd. has exercised its ex
01-06
Details -
Creating a Belt and Road Cooperation Model between China and Bangladesh, CASCO Supports the Full Opening of the "Dream Road"
DHAKA,Bangladesh,Jan. 3,2025-- On December 24,2024,the Padma Bridge Rail Link Project (PBRLP) in Bangladesh officially opened across its entire line to traffic. CASCO,one of the key Chinese participat
01-06
Details -
Chime Biologics and Mabgeek Achieve MG-K10 PPQ Milestone, Advancing Atopic Dermatitis and Asthma Therapies Antibody Drug MG-K10 Late-Stage Clinical Trials and Commercialization
Process Performance Qualification (PPQ) validates robust manufacturing standards and is crucial for regulatory compliance
01-06
Details